<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-903-SPI-22892</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">APIDC Biotech</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">The Biotechnology Venture Fund (APIDC Biotech, the Fund, or the company) was formed in May 2003 to make equity, equity-related and mezzanine investments in start-up and early stage life sciences businesses in India. APIDC Biotech is the first fund in India to focus exclusively on the life sciences sector and will seek opportunities in areas such as health care, drug discovery, agriculture, dairy, environmental and industrial applications all over the country. APIDC Biotech plans to take significant minority stakes and build a portfolio of 20 to 25 investee companies with average transaction size of around US$1-1.5 million. The Fund has a 10 year term and a 4 year commitment period.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN"></narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">THE BIOTECHNOLOGY VENTURE FUND</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SPI-22892" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2005-04-21" type="1"></activity-date>
  <activity-date iso-date="2005-11-08" type="2"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Sarath Naru, Managing Director
1102, Babukhan Estate, Basheerbagh
Hyderabad 500 001, Andhra Pradesh, India
Phone: 91 40 2329 9951
Fax:  91 40 2329 7449</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN"></narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="IN" percentage="100">
   <narrative xml:lang="EN">India</narrative>
  </recipient-country>
  <location ref="IN-India">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">The Fund is currently structured as a trust fund under the Indian Trust Act, and is registered with  the Securities and Exchange Board of India (SEBI). The geographic focus of the investments is India. The investment team operates from Hyderabad, India.</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>22.0000000000 79.0000000000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">BA - Private Equity/Venture Cap Fund - Country</narrative>
  </sector>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $4.00 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="510"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2005-04-21"></period-start>
   <period-end iso-date="2005-06-30"></period-end>
   <value currency="USD" value-date="2005-04-21">4000000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2005-04-21"></transaction-date>
   <value currency="USD" value-date="2005-04-21">4000000</value>
   <receiver-org>
    <narrative xml:lang="EN">THE BIOTECHNOLOGY VENTURE FUND</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="510"></finance-type>
  </transaction>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SPI/22892/apidc-biotech">
   <title>
    <narrative xml:lang="EN">Summary of Project Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
 </iati-activity>
</iati-activities>
